How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism? A cost-effectiveness analysis

Medicine and Dentistry

• Life Expectancy 100%
• Health Care Cost 66%
• Age 66%
• Primary Hyperparathyroidism 50%
• Patient 50%
• Therapeutic Procedure 50%
• Outpatient 33%
• Quality Adjusted Life Year 33%
• Inpatient 33%
• Observation 33%
• Sensitivity Analysis 16%
• Diagnosis 16%
• Monte Carlo Method 16%
• Parathyroidectomy 16%
• Analysis 16%
• Consensus 16%
• Health 16%
• Adjustment 16%
• Cost-Effectiveness Analysis 16%

INIS

• cost 66%
• patients 50%
• hyperparathyroidism 50%
• monte carlo method 16%
• simulation 16%
• conferences 16%
• utilities 16%
• multivariate analysis 16%
• cost effectiveness analysis 16%
• adjustments 16%
• sensitivity analysis 16%
• markov process 16%